Fungal Infections in Solid Organ Transplant Recipients

  • Peter G. Pappas


Organ transplantation is an effective life-sparing modality for thousands of patients with organ failure syndromes. In spite of important advances in surgical technique and immunosuppressive regimens that have made organ transplantation a safer procedure today when compared to previous decades, there remain substantial risks of infection and other complications related to these procedures. Among the infectious complications of organ transplantation, none is associated with a greater impact on morbidity and mortality than invasive fungal infections (IFI) [1–5]. Fungal infections in organ transplant recipients (OTRs) vary in frequency, etiology, and pathogenesis according to the type of organ transplant procedure. Variations in immunosuppressive regimens, surgical technique, infection control, and exposure history further complicate evaluation of these patients. Moreover, the incidence of IFIs among this group of patients varies considerably from center to center [6].


Transplant Recipient Candida Species Renal Transplant Recipient Invasive Aspergillosis Invasive Fungal Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis. 1993;16:677–88.PubMedGoogle Scholar
  2. 2.
    Hibberd PL, Rubin RH. Clinic aspects of fungal infection in organ transplant recipients. Clin Infect Dis. 1994;19 Suppl 1:33–40.Google Scholar
  3. 3.
    Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. Infect Dis Clin N Am. 1995;9:1045–74.Google Scholar
  4. 4.
    Dictar MO, Maiolo E, Alexander B, Jacob N, Veron MT. Mycoses in the transplanted patient. Med Mycol. 2000;38:251–8.PubMedGoogle Scholar
  5. 5.
    Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol. 2007;45:305–20.PubMedGoogle Scholar
  6. 6.
    Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients in the United States: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101–12.Google Scholar
  7. 7.
    Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS, editors. Clinical approach to infections in the compromised host. 3rd ed. New York: Plenum; 1994. p. 629–705.Google Scholar
  8. 8.
    Fishman JA. Infection in solid-organ transplant recipients. N Eng J Med. 2007;357:2601–14.Google Scholar
  9. 9.
    Patel R, Paya CV. Infections in solid organ transplant recipients. Clin Microbiol Rev. 1997;10:86–124.PubMedGoogle Scholar
  10. 10.
    Patel R. Infections in recipients of kidney transplants. Infect Dis Clin N Am. 2001;15:901–51.Google Scholar
  11. 11.
    Abbott KC, Hypolite I, Poropatich RK, et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis. 2001;3:203–11.PubMedGoogle Scholar
  12. 12.
    Singh N. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin N Am. 2003;17:113–34.Google Scholar
  13. 13.
    Cuellar-Rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis. 2009;49:710–6.PubMedGoogle Scholar
  14. 14.
    Wheat LJ, Smith EJ, Sathapatayavongs B, et al. Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch Intern Med. 1983;143:703–7.PubMedGoogle Scholar
  15. 15.
    Blair JE. Coccidioidomycosis in patients who have undergone transplantation. Ann NY Acad Sci. 2007;1111:365–76.PubMedGoogle Scholar
  16. 16.
    Heinz T, Perfect J, Schell W, Ditter E, Ruff G, Serafin D. Soft tissue fungal infections: surgical management of 12 immunocompromised patients. Plast Reconstr Surg. 1996;97:1391–9.PubMedGoogle Scholar
  17. 17.
    Chkhotua A, Yussim A, Tovar A, et al. Mucormycosis of the renal allograft: case report and review of the literature. Transpl Int. 2001;14:438–41.PubMedGoogle Scholar
  18. 18.
    Lussier N, Laverdiere M, Delorme J, Weiss K, Dandavino R. Trichosporon beigelii funguria in renal transplant recipients. Clin Infect Dis. 2000;31:1299–301.PubMedGoogle Scholar
  19. 19.
    Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis. 2002;34:467–76.PubMedGoogle Scholar
  20. 20.
    Nampoory MR, Khan ZU, Johny KV, et al. Invasive fungal infections in renal transplant recipients. J Infect. 1996;33:95–101.PubMedGoogle Scholar
  21. 21.
    Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore). 1999;78:123–38.Google Scholar
  22. 22.
    Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18:44–69.PubMedGoogle Scholar
  23. 23.
    Patterson JE, Peters J, Calhoon JH, et al. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2000;2:22–8.PubMedGoogle Scholar
  24. 24.
    Carlini A, Angelini D, Burrows L, DeQuirico G, Antonelli A. Cerebral aspergillosis: long term efficacy and safety of liposomal amphotericin B in kidney transplant. Nephrol Dial Transplant. 1998;13:2659–61.PubMedGoogle Scholar
  25. 25.
    Garcia A, Mazuecos A, Flayo A, et al. Isolated cerebral aspergillosis without a portal of entry-complete recovery after liposomal amphotericin B and surgical treatment. Nephrol Dial Transplant. 1998;9:2385–7.Google Scholar
  26. 26.
    Marin P, Garcia-Martos P, Carcia-Doncel A, et al. Endocarditis by Aspergillus fumigatus in a renal transplant. Mycopathologia. 1999;145:127–9.PubMedGoogle Scholar
  27. 27.
    Viertel A, Ditting T, Pistorius K, Geiger H, Scheuermann EH. Just-Nubling G. An unusual case of Aspergillus endocarditis in a kidney transplant recipient. Transplantation. 1999;68:1812–3.PubMedGoogle Scholar
  28. 28.
    Kim SW, Nah MY, Ueum CH, et al. Pelvic aspergillosis with tubo-ovarian abscess in a renal transplant recipient. J Infect. 2001;42:215–7.PubMedGoogle Scholar
  29. 29.
    Shirwany A, Sargent SJ, Dmochowski RR, Bronze MS. Urinary tract aspergillosis in a renal transplant recipient. Clin Infect Dis. 1998;27:1336.PubMedGoogle Scholar
  30. 30.
    Kaplan-Pavlovcic S, Masera A, Ovcak Z, Kmetec A. Prostatic aspergillosis in a renal transplant recipient. Nephrol Dial Transplant. 1999;14:1778–80.PubMedGoogle Scholar
  31. 31.
    Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7:1–14.Google Scholar
  32. 32.
    Singh N, Dromer F, Perfect JR, Lortholary O. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis. 2008;47:1321–7.PubMedGoogle Scholar
  33. 33.
    Lumbreras C, Fernandez I, Velosa J, Munn S, Sterioff S, Paya CV. Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. Clin Infect Dis. 1995;20:514–20.PubMedGoogle Scholar
  34. 34.
    Benedetti E, Gruessner AC, Troppmann C, et al. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. J Am Coll Surg. 1996;183:307–16.PubMedGoogle Scholar
  35. 35.
    Smets YF, van der Piji JW, van Dissel JT, Ringers FJ, de Fijter JW, Lemkes HH. Infectious disease complications of simultaneous pancreas kidney transplantation. Nephrol Dial Transplant. 1997;12:764–71.PubMedGoogle Scholar
  36. 36.
    Hesse UJ, Sutherland DER, Najarian JS, Simmons RL. Intra-abdominal infections in pancreas transplant recipients. Ann Surg. 1986;203:153–62.PubMedGoogle Scholar
  37. 37.
    Pirsch JD, Odorico JS, D’Alessandro AM, Knechtle SJ, Becker BN, Sollinger HW. Post-transplant infections in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. Transplantation. 1998;66:1746–50.PubMedGoogle Scholar
  38. 38.
    Wajszczuk CP, Dummer JS, Ho M, et al. Fungal infections in liver transplant recipients. Transplantation. 1985;40:347–53.PubMedGoogle Scholar
  39. 39.
    Singh N, Pruett TL, Houston S, et al. Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl. 2006;12:1205–9.PubMedGoogle Scholar
  40. 40.
    Singh N, Avery RK, Munoz P, et al. Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis. 2003;36:46–52.PubMedGoogle Scholar
  41. 41.
    Husain S, Tollemar J, Dominguez EA, et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation. 2003;75:2023–9.PubMedGoogle Scholar
  42. 42.
    Stelzmueller I, Lass-Floerl C, Geltner C, et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients. Transpl Int. 2008;21:534–46.PubMedGoogle Scholar
  43. 43.
    Sun HY, Singh N. Emerging importance of infections due to zygomycetes in organ transplant recipients. Int J Antimicrob Agents. 2008;32 Suppl 2:S115–8.PubMedGoogle Scholar
  44. 44.
    Sun HY, Aguado JM, Bonatti H, et al. Pulmonary zygomycosis in solid organ transplant recipients in the current era. Am J Transplant. 2009;9:2166–71.PubMedGoogle Scholar
  45. 45.
    Davis JA, Horn DL, Marr KA, Fishman JA. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS. Transpl Infect Dis. 2009;11:432–7.PubMedGoogle Scholar
  46. 46.
    Sun HY, Wagener MM, Singh N. Cryptococcosis in solid-organ, hemtopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. Clin Infect Dis. 2009;48:1566–76.PubMedGoogle Scholar
  47. 47.
    Collins LA, Samore MH, Roberts MS, et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis. 1994;170:644–52.PubMedGoogle Scholar
  48. 48.
    Patel R, Portela D, Badley AD, et al. Risk factors of invasive Candida or non-Candida fungal infections after liver transplantation. Transplantation. 1996;62:926–34.PubMedGoogle Scholar
  49. 49.
    Singh N, Aguado JM, Bonatti H, et al. Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis. 2009;200:1002–11.PubMedGoogle Scholar
  50. 50.
    Waser M, Maggiorini M, Luthy A, et al. Infectious complications in 100 consecutive heart transplant recipients. Eur J Clin Microbiol Infect Dis. 1994;13:12–8.PubMedGoogle Scholar
  51. 51.
    Kramer MR, Marshal SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation analysis of 200 episodes. Arch Intern Med. 1993;153:2010–6.PubMedGoogle Scholar
  52. 52.
    Grossi P, Glaudio F, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients. Transplantation. 2000;70:112–6.PubMedGoogle Scholar
  53. 53.
    Goldstein DJ, El-Amir NG, Ashton RC, et al. Fungal infections in left ventricular assist device recipients: incidence, prophylaxis, and treatment. ASAIO J. 1995;41:873–5.PubMedGoogle Scholar
  54. 54.
    Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 1997;16:822–31.PubMedGoogle Scholar
  55. 55.
    Gordon SM, Avery RK. Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transpl Infect Dis. 2001;3:161–7.PubMedGoogle Scholar
  56. 56.
    Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant. 2003;22:258–66.PubMedGoogle Scholar
  57. 57.
    Mehrad B, Giusppe P, Martinez FJ, Clark T, Iannettoni MD, Lynch JP. Spectrum of Aspergillus infection in lung transplant recipients. Chest. 2001;119:169–75.PubMedGoogle Scholar
  58. 58.
    Yeldandi V, Laghi F, McCabe MA, et al. Aspergillus and lung transplantation. J Heart Lung Transplant. 1995;14:883–90.PubMedGoogle Scholar
  59. 59.
    Westney GE, Kesten S, de Hoyos A, Chapparro C, Winton T, Maurer JR. Aspergillus infection in single and double lung transplant recipients. Transplantation. 1996;61:915–9.PubMedGoogle Scholar
  60. 60.
    Cahill BC, Hibbs JR, Savik K, et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest. 1997;112:1160–4.PubMedGoogle Scholar
  61. 61.
    Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis. 1998;26:753–5.PubMedGoogle Scholar
  62. 62.
    Goldfarb NS, Avery RK, Goormastic M, et al. Hypogammaglobu­linemia in lung transplant recipients. Transplantation. 2001;71:242–6.PubMedGoogle Scholar
  63. 63.
    Marks WH, Florence L, Lieberman J, et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation. 1996;61:1771–83.PubMedGoogle Scholar
  64. 64.
    Nunley DR, Ohori NP, Grgurich WF, et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest. 1998;114:1321–9.PubMedGoogle Scholar
  65. 65.
    Cimon B, Carrere J, Vinatier JF, Chazalette JP, Chabasse D, Bouchara JP. Clinical significance to Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2000;19:53–6.PubMedGoogle Scholar
  66. 66.
    Horn DL, Neofytos D, Anaissie EJ, et al. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis. 2009;48:1695–703.PubMedGoogle Scholar
  67. 67.
    Dauber HJ, Paradis IL, Dummer JS. Infectious complications in pulmonary allograft recipients. Clin Chest Med. 1990;11:291–308.PubMedGoogle Scholar
  68. 68.
    Kanj SS, Welty-Wolf K, Madden J, et al. Fungal infections in lung and heart transplant recipients: report of 9 cases and review of the literature. Medicine (Baltimore). 1996;75:142–56.Google Scholar
  69. 69.
    Rodriguez M, Fishman JA. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients. Clin Microbiol Rev. 2004;17:770–82.PubMedGoogle Scholar
  70. 70.
    Reyes J, Abu-Elmagd K, Tzakis A, et al. Infectious complications after human small bowel transplantation. Transplantation. 1992;24:1249–50.Google Scholar
  71. 71.
    Kusne S, Furukawa H, Abu-Elmagd K, et al. Infectious complications after small bowel transplantation in adults: an update. Transplant Proc. 1996;28:2761–2.PubMedGoogle Scholar
  72. 72.
    Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis. 2005;7:109–15.PubMedGoogle Scholar
  73. 73.
    Peddi VR, Hariharan S, First MR. Disseminated histoplasmosis in renal allograft recipients. Clin Transplant. 1996;10:160–5.PubMedGoogle Scholar
  74. 74.
    Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24:369–74.PubMedGoogle Scholar
  75. 75.
    Singh N, Limaye AP, Forrest G, et al. Late-onset invasive aspergillosis in organ transplant recipients in the current era. Med Mycol. 2006;44:445–9.PubMedGoogle Scholar
  76. 76.
    Issa NC, Fishman JA. Infectious complications of antilymphocyte therapies in solid organ transplantation. Clin Infect Dis. 2009;48:772–86.PubMedGoogle Scholar
  77. 77.
    The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppresion in liver transplantation. N Engl J Med. 1994;331:1110–5.Google Scholar
  78. 78.
    Bernabeu-Wittel M, Naranjo M, Cisneros JM, et al. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression. Eur J Clin Microbiol Infect Dis. 2002;21:173–80.PubMedGoogle Scholar
  79. 79.
    Kontoyiannis DP, Lewis RE, Alexander BD, et al. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 2008;52:735–8.PubMedGoogle Scholar
  80. 80.
    Wong SY, Allen DM. Transmission of disseminated histoplasmosis via cadaveric renal transplantation: case report. Clin Infect Dis. 1992;14:232–4.PubMedGoogle Scholar
  81. 81.
    Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med. 2000;343:1163–6.PubMedGoogle Scholar
  82. 82.
    Wright P, Pappagianis D, Davis CA, et al. Transmission of Coccidioides immitis from donor organs: a description of two fatal cases of disseminated coccidioidomycosis. Clin Infect Dis. 2003;37:1265–9.PubMedGoogle Scholar
  83. 83.
    Brugière O, Forget E, Biondi G, et al. Coccidioidomycosis in a lung transplant recipient acquired from the donor graft in France. Transplantation. 2009;88:1319–20.PubMedGoogle Scholar
  84. 84.
    Tripathy U, Yung GL, Kriett JM, Thistlewaite PA, Kapelanski DP, Jamieson SW. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thoracic Surg. 2002;73:306–8.Google Scholar
  85. 85.
    Battaglia M, Ditonno P, Fiore T, De Ceglie G, Regina G, Selvaggi FP. True mycotic arteritis by Candida albicans in 2 kidney transplant recipients from the same donor. J Urol. 2000;163:1236–7.PubMedGoogle Scholar
  86. 86.
    Albano L, Bretagne S, Mamzer-Bruneel MF, et al. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin Infect Dis. 2009;48:194–202.PubMedGoogle Scholar
  87. 87.
    Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF. Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest. 1996;109:1119–24.PubMedGoogle Scholar
  88. 88.
    Safdar N, Slattery WR, Knasinski V, et al. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis. 2005;40:1413–21.PubMedGoogle Scholar
  89. 89.
    Gallis HA, Berman RA, Cate TR, Hamilton JD, Gunnels JC, Stickel DL. Fungal infections following renal transplantation. Arch Intern Med. 1975;135:1163–72.PubMedGoogle Scholar
  90. 90.
    Ciancio G, Burke GW, Viciana AL, et al. Destructive allograft fungal arteritis following simultaneous pancreas-kidney transplantation. Transplantation. 1996;61:1172–5.PubMedGoogle Scholar
  91. 91.
    Potti A, Danielson B, Sen K. “True” mycotic aneurysm of a renal artery allograft. Am J Kidney Dis. 1998;31:E3.PubMedGoogle Scholar
  92. 92.
    Dowling RD, Baladi N, Zenati M, et al. Disruption of the aortic anastomosis after heart-lung transplantation. Ann Thoracic Surg. 1990;49:118–22.Google Scholar
  93. 93.
    Ralph ED, Hussain Z. Chronic meningitis caused by Candida albicans in a liver transplant recipient: usefulness of the polymerase chain reaction for diagnosis and for monitoring treatment. Clin Infect Dis. 1996;23:191–2.PubMedGoogle Scholar
  94. 94.
    Choi IS, Kim SJ, Kim BY, et al. Candida polyarthritis in a renal transplant patient: case report of a patient successfully treated with amphotericin B. Transplant Proc. 2000;32:1963–4.PubMedGoogle Scholar
  95. 95.
    Balajee SA, Kano R, Baddley JW, et al. Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol. 2009;47:3138–41.PubMedGoogle Scholar
  96. 96.
    Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis: disease spectrum, treatment, practice, and outcomes. Medicine (Baltimore). 2000;79:250–60.Google Scholar
  97. 97.
    Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systemic review of the literature. Clin Infect Dis. 2001;32:658–66.Google Scholar
  98. 98.
    Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis. 1991;144:552–8.PubMedGoogle Scholar
  99. 99.
    Sayiner A, Kursat S, Toz H, Duman S, Onal B, Tumbay E. Pseudomembranous necrotizing bronchial aspergillosis in a renal transplant recipient. Nephrol Dial Transplant. 1999;14:1784–5.PubMedGoogle Scholar
  100. 100.
    Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med. 1996;100:171–8.PubMedGoogle Scholar
  101. 101.
    Brown RS, Lake JR, Katzman BA, et al. Incidence of significance of Aspergillus cultures following liver and kidney transplantation. Transplantation. 1996;61:666–9.PubMedGoogle Scholar
  102. 102.
    Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824–33.PubMedGoogle Scholar
  103. 103.
    Husain S, Paterson DL, Studer SM, et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation. 2007;83:1330–6.PubMedGoogle Scholar
  104. 104.
    Patterson JE. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis. 1999;1:229–36.PubMedGoogle Scholar
  105. 105.
    Kapoor A, Flechner SM, O’Malley K, Paolone D, File TM, Cutrona AF. Cryptococcal meningitis in renal transplant patients associated with environmental exposure. Transplant Infect Dis. 1999;1:213–7.Google Scholar
  106. 106.
    Hunger RE, Paredes BE, Quattroppani C, Krahenbuhl S, Braathen LR. Primary cutaneous cryptococcosis in a patient with systemic immunosuppression after liver transplantation. Dermatology. 2000;200:352–5.PubMedGoogle Scholar
  107. 107.
    Nosanchuk JD, Shoham S, Fries BC, Shapiro S, Levitz SM, Casadevall A. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000;132:205–8.PubMedGoogle Scholar
  108. 108.
    Anderson DJ, Schmidt C, Goodman J, Pomeroy C. Cryptococcal disease presenting as cellulitis. Clin Infect Dis. 1992;14:666–72.PubMedGoogle Scholar
  109. 109.
    Baer S, Baddley JW, Gnann JW, Pappas PG. Cryptococcal disease presenting as necrotizing cellulitis in transplant recipients. Transpl Infect Dis. 2009;11:353–8.PubMedGoogle Scholar
  110. 110.
    Chandesris LF, MO PS, et al. Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient. Am J Transplant. 2007;7:2826–8.PubMedGoogle Scholar
  111. 111.
    Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33:690–9.PubMedGoogle Scholar
  112. 112.
    Singh N, Alexander BD, Lortholary O, et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis. 2007;195:756–64.PubMedGoogle Scholar
  113. 113.
    Singh N, Perfect JR. Immune reconstitution syndrome associated with opportunistic mycoses. Lancet Infect Dis. 2007;7:395–401.PubMedGoogle Scholar
  114. 114.
    Singh N, Lortholary O, Alexander BD, et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis. 2005;40:1756–61.PubMedGoogle Scholar
  115. 115.
    Singh N, Lortholary O, Alexander BD, et al. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation. 2005;80:1131–3.PubMedGoogle Scholar
  116. 116.
    Singh N, Lortholary O, Dromer F, et al. Central nervous system cryptococcis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation. 2008;86:647–51.PubMedGoogle Scholar
  117. 117.
    Demirag A, Elkhammas EA, Henry ML, et al. Pulmonary Rhizopus infection in a diabetic renal transplant recipient. Clin Transplant. 2000;14:8–10.PubMedGoogle Scholar
  118. 118.
    Lee E, Vershvovsky Y, Miller F, Waltzer W, Suh H, Nord EP. Combined medical surgical therapy for pulmonary mucormycosis in a diabetic renal allograft recipient. Am J Kidney Dis. 2001;38:E37.PubMedGoogle Scholar
  119. 119.
    Jimenez C, Lumbreras C, Aguado JM, et al. Successful treatment of Mucor infection after liver or pancreas-kidney transplantation. Transplant. 2002;73:476–80.Google Scholar
  120. 120.
    Walker SD, Clark RV, King CT, Humphries JE, Lytle LS, Butkus DE. Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Review. Am J Clin Pathol. 1992;98:559–64.PubMedGoogle Scholar
  121. 121.
    Sheu BS, Lee PC, Yang HB. A giant gastric ulcer caused by mucormycosis infection in a patient with renal transplantation. Endoscopy. 1998;30:S60–1.PubMedGoogle Scholar
  122. 122.
    Ju JH, Park HS, Shin MJ, et al. Successful treatment of massive lower gastrointestinal bleeding caused by mixed infection of cytomegalovirus and mucormycosis in a renal transplant recipient. Am J Nephrol. 2001;21:232–6.PubMedGoogle Scholar
  123. 123.
    Timmouth J, Baker J, Gardiner G. Gastrointestinal mucormycosis in a renal transplant patient. Can J Gastroenterol. 2001;15:269–71.Google Scholar
  124. 124.
    Gold WL, Vellend H, Salit IE, et al. Successful treatment of systemic and local infections due to Exophiala spp. Clin Infect Dis. 1994;19:339–41.PubMedGoogle Scholar
  125. 125.
    Salama AD, Rogers T, Lord GM, Lechler RI, Mason PD. Multiple Cladosporium brain abscesses in a renal transplant patient: aggressive management improves outcome. Transplantation. 1997;63:160–2.PubMedGoogle Scholar
  126. 126.
    von Eiff C, Bettin D, Proctor RA, et al. Phaeocremonium parasiticum infective endocarditis following liver transplantation. Clin Infect Dis. 1997;25:1251–3.Google Scholar
  127. 127.
    Mesa A, Henao J, Gil M, Durango G. Phaeohyphomycosis in kidney transplant patients. Clin Transplant. 1999;13:273–6.PubMedGoogle Scholar
  128. 128.
    Malani PN, Bleicher JJ, Kauffman CA, Davenport DS. Disseminated Dactylaria constricta infection in a renal transplant recipient. Transpl Infect Dis. 2001;3:40–3.PubMedGoogle Scholar
  129. 129.
    Castro LG, da Silva Lacaz C, Guarro J, et al. Phaeohyphomycotic cyst caused by Colletotrichum crassipes. J Clin Microbiol. 2001;39:2321–4.PubMedGoogle Scholar
  130. 130.
    Magina S, Libosa C, Santos P, et al. Cutaneous alternariosis by Alternaria chartarum in a renal transplanted patient. Br J Dermatol. 2000;142:1261–2.PubMedGoogle Scholar
  131. 131.
    Halaby T, Boots H, Vermeulen A, et al. Phaeohyphomycosis caused by Alternaria infectoria in a renal transplant recipient. J Clin Microbiol. 2001;39:1952–5.PubMedGoogle Scholar
  132. 132.
    Blair JE. Coccidioidomycosis in liver transplantation. Liver Transplant. 2006;12:31–9.Google Scholar
  133. 133.
    Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33:1536–44.PubMedGoogle Scholar
  134. 134.
    Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant. 2006;6:340–5.PubMedGoogle Scholar
  135. 135.
    Marques SA, Hozumi S, Camargo RM, Carvalho MF, Marques ME. Histoplasmosis presenting as cellulitis 18 years after renal transplantation. Med Mycol. 2008;46:725–8.PubMedGoogle Scholar
  136. 136.
    McGuinn ML, Lawrence ME, Proia L, Segreti J. Progressive disseminated histoplasmosis presenting as cellulitis in a renal transplant recipient. Transplant Proc. 2005;37:4313–4.PubMedGoogle Scholar
  137. 137.
    Bacal F, Andrade AC, Migueletto BC, et al. Histoplasmosis as a late infectious complication following heart transplantation in a patient with Chagas’ disease. Arquivos Brasileiors de Cardiologia. 2001;76:403–8.Google Scholar
  138. 138.
    Botterel F, Romand S, Saliba F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis. 1999;18:662–4.PubMedGoogle Scholar
  139. 139.
    Livas IC, Nechay PS, Nauseef WM. Clinical evidence of spinal and cerebral histoplasmosis twenty years after renal transplantation. Clin Infect Dis. 1995;20:692–5.PubMedGoogle Scholar
  140. 140.
    Zainudin BM, Kassim F, Annuar NM, Lim CS, Ghazali AK, Murad Z. Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient. J Trop Med Hygiene. 1992;95:276–9.Google Scholar
  141. 141.
    Brett MT, Kwan JT, Bending MR. Caecal perforation in a renal transplant patient with disseminated histoplasmosis. J Clin Pathol. 1988;41:992–5.PubMedGoogle Scholar
  142. 142.
    Cohen IM, Galgini JN, Potter D, Ogden DA. Coccidioidomycosis in renal transplant replacement therapy. Arch Intern Med. 1982;142:489–94.PubMedGoogle Scholar
  143. 143.
    Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis. 1993;16:54–8.PubMedGoogle Scholar
  144. 144.
    Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis. 2007;9:310–7.PubMedGoogle Scholar
  145. 145.
    Pappas PG, Threlkeld MG, Bedsole GD, Cleveland KO, Gelfand MS, Dismukes WE. Blastomycosis in immunocompromised patients. Medicine (Baltimore). 1994;72:311–25.Google Scholar
  146. 146.
    Agarwal SK, Tiwari SC, Dash SC, et al. Urinary sporotrichosis in a renal allograft recipient. Nephron. 1994;66:485.PubMedGoogle Scholar
  147. 147.
    Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis. 1987;9:369–75.PubMedGoogle Scholar
  148. 148.
    Guarro J, Nucci M, Akiti T, Gene J, Barreiro MD, Goncalves RT. Fungemia due to Fusarium sacchari in an immunosuppressed patient. J Clin Microbiol. 2000;38:419–21.PubMedGoogle Scholar
  149. 149.
    Sampathkumar P, Paya CV. Fusarium infection after solid-organ transplantation. Clin Infect Dis. 2001;32:1237–40.PubMedGoogle Scholar
  150. 150.
    Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood. 1997;90:999–1008.PubMedGoogle Scholar
  151. 151.
    Clark NM. Paecilomyces lilacinus infection in a heart transplant recipient and successful treatment with terbinafine. Clin Infect Dis. 1999;28:1169–70.PubMedGoogle Scholar
  152. 152.
    Blackwell W, Ahmed K, O’Docherty C, Hay RJ. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus in a renal transplant patient. Br J Dermatol. 2000;143:873–5.PubMedGoogle Scholar
  153. 153.
    Hilmarsdottir I, Thorsteinsson SB, Asmundsson P, Bodvarsson M, Arnadottir M. Cutaneous infection caused by Paecilomyces lilacinus in a renal transplant patient: treatment with voriconazole. Scand J Infect Dis. 2000;32:331–2.PubMedGoogle Scholar
  154. 154.
    Guarro J, Antolin Ayala MI, Gene J, Gutierrez-Calzada J, Nieves-Diez C, Ortoneda M. Fatal case of Trichoderma harzianum infection in a renal transplant recipient. J Clin Microbiol. 1999;37:3751–5.PubMedGoogle Scholar
  155. 155.
    Gordon SM, LaRosa SP, Kalmadi S, et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis. 1999;28:240–6.PubMedGoogle Scholar
  156. 156.
    Torre-Cisneros J, De la Mata M, Pozo JC, et al. Randomized trial of weekly sulfadoxine/pyrimethamine versus daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation. Clin Infect Dis. 1999;29:771–4.PubMedGoogle Scholar
  157. 157.
    De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of the EORTC/MSG Consensus Group for invasive fungal diseases. Clin Infect Dis. 2008;46:1813–21.PubMedGoogle Scholar
  158. 158.
    Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1,3) β-D glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis. 2005;41:654–9.PubMedGoogle Scholar
  159. 159.
    Husain S, Kwak EJ, Obman A, et al. Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant. 2004;4:796–802.PubMedGoogle Scholar
  160. 160.
    Winston DJ, Pakrasi A, Busuttil RW. Prophylactic fluconazole in liver transplant recipients: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131:729–37.PubMedGoogle Scholar
  161. 161.
    Tollemar J, Hockerstedt K, Ericzon BG, Jalanko H, Ringden O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. Transplantation. 1995;59:45–50.PubMedGoogle Scholar
  162. 162.
    Pappas PG, Andes D, Schuster M, et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant. 2006;6:386–91.PubMedGoogle Scholar
  163. 163.
    Hadley S, Huckabee C, Pappas PG, et al. Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis. 2009;11:40–8.PubMedGoogle Scholar
  164. 164.
    Marty FM, Rubin RH. The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy. Transpl Int. 2006;19:2–11.PubMedGoogle Scholar
  165. 165.
    Palmer SM, Drew RH, Whitehouse JD, et al. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation. 2001;72:545–8.PubMedGoogle Scholar
  166. 166.
    Monforte V, Roman A, Gavalda J, et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant. 2001;20:1274–81.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of Infectious DiseasesUniversity of Alabama at Birmingham School of MedicineBirminghamUSA

Personalised recommendations